Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 24Fluorouracil 20Capecitabine 16pembrolizumab 15Nivolumab 15Leucovorin 13Trastuzumab 9fludarabine 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8S 1 (combination) 7trastuzumab deruxtecan 6Specimen Handling 6Cisplatin 6Magnetic Resonance Spectroscopy 5Bevacizumab 5zolbetuximab 4Irinotecan 4Biopsy 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Diagnostic Imaging × 90 days × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡